Skip to main content
. 2011 Oct 3;11(1A):S86–S92. doi: 10.1102/1470-7330.2011.9022

Table 4.

Increases in survival by use of FDG-PET on completion of therapy for Hodgkin lymphoma (from Bradbury et al.[19])

Scenario Increase in survival compared with surveillance for all patients (years) Increase in survival compared with consolidation for all patients (years)
Female 20 years 1.2 0.7
Female 40 years 1.6 0.6
Female 40 years 0.7 1.6
Male 20 years 1.5 0.6
Male 40 years 1.3 0.9
Male 60 years 0.4 2.0